April 9, 2019 – April 10, 2019
South San Francisco, California, USA
The field of immunotoxicology is a dynamic one in which changing public health concerns, novel biomedical research advances, and innovative technological developments constantly change the landscape and the way in which work is carried out and utilized. As this field requires combined expertise in both immunology and toxicology, the need for continued training and interdisciplinary interactions are critical for those who work within this field. This is essential both for those with an immunology background who seek to apply this expertise to drug development and safety, as well as those who wish to enhance their current drug safety expertise with a deeper understanding of immunology.
March 29, 2019
Silver Spring, USA
FDA Public Workshop on Leveraging Human-Relevant Cardiomyocytes in Nonclinical Studies to Provide Mechanistic Insights into Cardiovascular Safety Liabilities
October 17, 2018 – October 18, 2018
Copenhagen , Denmark
October 1, 2018 – October 2, 2018
Silver Spring, Maryland, USA
With the emergence of CD3 bispecifics as a novel weapon in the fight against cancer, there is a growing need to share information and learnings about these compounds that range from strategies for target expression profiling to nonclinical safety assessment to clinical experience. This workshop is designed to engage with a multi-stakeholder group of experts that will present and discuss their case examples with the objectives of learning from each other through robust engagement and discussion to enable the best outcomes for patients
June 25, 2018 – June 26, 2018
Alexandria, VA, United States
A 2-day workshop to address the state of the science and data gaps in gut microbiome research.